DA-3201

N/A

Report date: 2022/01/24 13:25:20

Base Information

Drug NameDA-3201
Drug Alias NameRecombinant basic fibroblast growth factor (Dong-A)DA-3201
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionFibroblast growth factor receptors modulatorsInterferon alpha/beta receptor agonists
TargetsFibroblast growth factor receptorsInterferon alpha/beta receptor
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDong-A Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDong-A Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A